These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26539588)

  • 1. Effects of chloroquine therapy on white blood cells.
    Rongey C; Cherian S
    Blood; 2015 Aug; 126(9):1149. PubMed ID: 26539588
    [No Abstract]   [Full Text] [Related]  

  • 2. [Respiratory infection in a man with systemic lupus erythematosus].
    Medicina (B Aires); 1996; 56(4):405-13. PubMed ID: 9138347
    [No Abstract]   [Full Text] [Related]  

  • 3. The toxic effect on leukocyte lineage of antimicrobial therapy in urinary and respiratory infections.
    Junuzovic D; Zunic L; Dervisefendic M; Skopljak A; Pasagic A; Masic I
    Med Arch; 2014 Jun; 68(3):167-9. PubMed ID: 25568526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive hemophagocytic syndrome in a case of systemic lupus erythematosus that was diagnosed by detection of hemophagocytosing macrophages in peripheral blood smears.
    Hagiwara K; Sawanobori M; Nakagawa Y; Sato T; Akiyama O; Takemura T
    Mod Rheumatol; 2006; 16(3):169-71. PubMed ID: 16767556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus.
    Lesiak A; Narbutt J; Sysa-Jedrzejowska A; Lukamowicz J; McCauliffe DP; Wózniacka A
    Lupus; 2010 May; 19(6):683-8. PubMed ID: 20064914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The toxic effect on leukocyte lineage of antimicrobial therapy in urinary and respiratory infections.
    Junuzovic D; Zunic L; Dervisefendic M; Skopljak A; Pasagic A; Masic I
    Med Arh; 2014; 68(3):167-9. PubMed ID: 25195344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vacuolar myopathy in a patient with positive LE cell preparations.
    Sibrans DF; Holley HL
    Arthritis Rheum; 1967 Apr; 10(2):141-50. PubMed ID: 6023056
    [No Abstract]   [Full Text] [Related]  

  • 8. Ocular involvement in lupus erythematosus profundus (panniculitis).
    Nowinski T; Bernardino V; Naidoff M; Parrish R
    Ophthalmology; 1982 Oct; 89(10):1149-54. PubMed ID: 7155526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of ofloxacin in acute exacerbations of chronic respiratory disease.
    Watanabe K; Yoshida M; Ishibashi T; Yamada H; Kido M; Hirose T; Maeda F; Matsuzaki Y
    Drugs; 1995; 49 Suppl 2():448-50. PubMed ID: 8549396
    [No Abstract]   [Full Text] [Related]  

  • 10. [Leukocytal osmotic resistance in chronic erythematosus in relation to chloroquine treatment].
    CHIEREGATO GC; BRESSANIN S
    Minerva Dermatol; 1961 Mar; 36():83-6. PubMed ID: 13693062
    [No Abstract]   [Full Text] [Related]  

  • 11. Borderline tuberculoid leprosy coexisting with systemic lupus erythematosus.
    Zorbas P; Kontochristopoulos G; Detsi I; Apostolakis E; Kouris N; Katsambas A
    J Eur Acad Dermatol Venereol; 1999 May; 12(3):274-5. PubMed ID: 10461657
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibitory effect of ofloxacin on acute exacerbations of chronic respiratory tract infections in comparison with erythromycin.
    Kawahara S; Watanabe Y; Matsuka Y; Sato T; Takahashi K
    Drugs; 1995; 49 Suppl 2():414-5. PubMed ID: 8549382
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of mycophenolate mofetil on the white blood cell count and the frequency of infection in systemic lupus erythematosus.
    Subedi A; Magder LS; Petri M
    Rheumatol Int; 2015 Oct; 35(10):1687-92. PubMed ID: 25836768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [DNA-synthesizing lymphocytes in the blood of patients with disseminated lupus erythematosus, rheumatoid arthritis, and panarteritis nodosa (author's transl)].
    Huber C; Günther R; Michlmayr G; Huber H; Braunsteiner H
    Wien Klin Wochenschr; 1973 Feb; 85(6):92-5. PubMed ID: 4155172
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of acute systemic lupus erythematosus with extensive muscle atrophy; necessity of differentiation from dermatomyositis; positive effect of therapy with prednisone and nivaquine].
    DYK T
    Pol Arch Med Wewn; 1958; 28(3):353-61. PubMed ID: 13553977
    [No Abstract]   [Full Text] [Related]  

  • 16. Ciprofloxacin in the treatment of serious infections in systemic lupus erythematosus.
    Oh HM; Koh WH; Boey ML
    Drugs; 1995; 49 Suppl 2():486-7. PubMed ID: 8549410
    [No Abstract]   [Full Text] [Related]  

  • 17. Direct susceptibility testing of respiratory samples.
    Shah PM
    Clin Infect Dis; 2007 Aug; 45(3):401; author reply 401-3. PubMed ID: 17599328
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic lupus erythematosus flare-up manifesting as a cilioretinal artery occlusion.
    el-Asrar AM; Naddaf HO; al-Momen AK; al-Balla SR
    Lupus; 1995 Apr; 4(2):158-60. PubMed ID: 7795623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causative organisms in acute exacerbation of chronic airways disease and response to ofloxacin therapy.
    Sufarlan AW; Zainudin BM; Pit S; Ishak I
    Drugs; 1995; 49 Suppl 2():442-5. PubMed ID: 8549394
    [No Abstract]   [Full Text] [Related]  

  • 20. [Histomorphology and histochemistry of changes in the dermo-epidermal area in lupus erythematosus prior to and following treatment with chloroquine phosphate].
    Bajdekoff B; Hadjioloff AI; Zvetkova E; Velev N; Mintschev I
    Dermatol Monatsschr; 1973 Sep; 159(9):880-5. PubMed ID: 4770773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.